Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

The big game didn't live up to the big billing, but there was plenty to take in during commercial breaks and halftime.

Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...

ImmunityBio, Inc. , a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has authorized an expanded access program (EAP) that will bring a vital alternative ...

Well, a global provider of genomic library and multiplexing workflow solutions, today announced the early access availability of the new MosaiXtm Library Prep Kit, designed for demanding applications ...

Coastal Carolina University unveils its top 5 and bottom 5 for the 2025 USA TODAY Ad Meter Marketing Spotlight. See which ...

According to the author of the study: "If the U.S. were to sustain a national hospital occupancy of 85 percent or greater, it is likely that we would see tens to hundreds of thousands of excess ...

Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.

The transformative HIMS program's expansion aims to streamline services for better efficiency and transparency. (With inputs from agencies.) ...

Telehealth pioneer Hims & Hers Health (HIMS) stock is soaring, with a 12% gain in recent days and a whopping 176% in the last three months.

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...

In this article, we are going to take a look at where Hims & Hers Health Inc. (NYSE:HIMS) stands against other firms that posted double-digit gains on Thursday. Wall Street’s main indices ...